AIC
COCP icon

Archer Investment Corporation’s Cocrystal Pharma COCP Stock Holding History

Archer Investment Corporation’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-84
Closed -$157 – 1066
2023
Q3 		$157 Hold
84
– – ﹤0.01% 999
2023
Q2 		$201 Hold
84
– – ﹤0.01% 968
2023
Q1 		$167 Hold
84
– – ﹤0.01% 835
2022
Q4 		$164 Buy
84
+1
+1% +$3 ﹤0.01% 807
2022
Q3 		$291 Hold
83
– – ﹤0.01% 783
2022
Q2 		$410 Hold
83
– – ﹤0.01% 781
2022
Q1 		$510 Hold
83
– – ﹤0.01% 777
2021
Q4 		$650 Hold
83
– – ﹤0.01% 755
2021
Q3 		$1.05K Hold
83
– – ﹤0.01% 676
2021
Q2 		$1.25K Buy
83
+41
+98% +$623 ﹤0.01% 552
2021
Q1 		$695 Buy
+42
New +$853 ﹤0.01% 716

Other funds holding COCP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Archer Investment Corporation's COCP Position: Q4 2023 in Review

Archer Investment Corporation sold out of Cocrystal Pharma (COCP) in Q4 2023, closing a stake of 84 shares — an estimated $157 sold.

Archer Investment Corporation first reported a position in COCP in Q1 2021 and held it in 11 quarters. The position peaked at $1.25K in Q2 2021. 17 funds tracked by Wall St. Rank hold COCP as of Q4 2023.

  • Archer Investment Corporation reported no remaining Cocrystal Pharma position as of Q4 2023 after selling out during the quarter.
  • Archer Investment Corporation sold 84 Cocrystal Pharma shares in Q4 2023, an estimated $157.
  • Archer Investment Corporation first reported a position in Cocrystal Pharma in Q1 2021 and held it in 11 quarters.
  • Archer Investment Corporation's Cocrystal Pharma position peaked at $1.25K in Q2 2021.
  • 17 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q4 2023.

Based on Archer Investment Corporation's 13F filing for Q4 2023, filed 31 Jan 2024.